2019 March 26 Tuesday
നീതി ലഭ്യമാക്കാനുള്ള എളുപ്പമാര്‍ഗം മറ്റുള്ളവര്‍ക്കു നീതി വാങ്ങിക്കൊടുക്കലാണ്. -മഹാത്മജി

Nobel Prize for the Medicine Declared; Immunologists wins for cancer treatment

Stockholms: James P. Allison of America and Tasuku Honjo of Japan, two immunologists won the 2018 Nobel Prize for for their discovery of ‘immune checkpoint therapy,’ a cancer treatment. The two were awarded the Prize “for their discovery of cancer therapy by inhibition of negative immune regulation’ in the field Medicine for discoveries leading to new approaches in harnessing the immune system to fight cancer.

Medicine is the first of the Nobel Prizes awarded each year. The prizes for achievements in science, literature and peace were created in accordance with the will of dynamite inventor and businessman Alfred Nobel and have been awarded since 1901. The literature prize will not be handed out this year after the awarding body was hit by a sexual misconduct scandal. Both laureates studied proteins that prevent the body and its main immune cells, known as T-cells, from attacking tumour cells effectively.

Allison, professor at the University of Texas MD Anderson Cancer Center, studied a protein that functions as a brake on the immune system and realised the potential for unleashing immune cells to attack tumours if the brake could be released. Honjo, professor at Kyoto University since 1984, separately discovered a second protein on immune cells and revealed that it too operated as a brake, but with a different mechanism.

“Cancer kills millions of people every year and is one of humanity’s greatest health challenges. By stimulating the inherent ability of our immune system to attack tumor cells this year’s Nobel Laureates have established an entirely new principle for cancer therapy,” read a statement from the Academy.


ഏറ്റവും പുതിയ വാർത്തകൾക്കും വീഡിയോകൾക്കും സബ്‌സ്ക്രൈബ് ചെയ്യുക

കമന്റ് ബോക്‌സിലെ അഭിപ്രായങ്ങള്‍ സുപ്രഭാതത്തിന്റേതല്ല. വായനക്കാരുടേതു മാത്രമാണ്. അശ്ലീലവും അപകീര്‍ത്തികരവും ജാതി, മത, സമുദായ സ്പര്‍ധവളര്‍ത്തുന്നതുമായ അഭിപ്രായങ്ങള്‍ പോസ്റ്റ് ചെയ്യരുത്. ഇത്തരം അഭിപ്രായങ്ങള്‍ രേഖപ്പെടുത്തുന്നത് കേന്ദ്രസര്‍ക്കാറിന്റെ ഐടി നയപ്രകാരം ശിക്ഷാര്‍ഹമാണ്.

Latest News